1. Home >
  2. Companies >
  3. Life Science >
  4. Germany >
  5. Ganymed Pharmaceuticals AG

Ganymed Pharmaceuticals AG - Ownership and Business Overview

Life ScienceCompany

Ganymed Pharmaceuticals AG Ownership

Who owns Ganymed Pharmaceuticals AG?

Ganymed Pharmaceuticals AG is owned by Astellas Pharma. It was acquired on October 28, 2016.

Ganymed Pharmaceuticals AG Business Overview

Where is Ganymed Pharmaceuticals AG headquartered?

Ganymed Pharmaceuticals AG is headquartered in Mainz, Germany.

How many employees does Ganymed Pharmaceuticals AG have?

Ganymed Pharmaceuticals AG has 85 employees.

What sector is Ganymed Pharmaceuticals AG in?

Ganymed Pharmaceuticals AG is a life science company.

When was Ganymed Pharmaceuticals AG founded?

Ganymed Pharmaceuticals AG was founded in 2001.

Life Science M&A Summary in 2016

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.

Subscribe to Mergr to view all 298 acquisitions of life science companies in 2016, including 35 acquisitions by private equity firms, and 263 by strategics.

Ganymed Pharmaceuticals AG

An der Goldgrube 12,
Mainz, 55131
Germany,
+49 6131 1440100
www.ganymed-pharmaceuticals.com

Ganymed Pharmaceuticals AG is a biopharmaceutical company developing a new class of immunotherapeutic cancer drugs called Ideal Monoclonal Antibodies (IMABs). IMABs are unique in that they are highly selective for proteins which are present on tumor cells, but do not bind to healthy cells. This unmatched tumor cell specificity makes IMABs cancer cell selective allowing them to efficiently kill tumor cells without harming normal healthy tissues.


Company Summary

SECTOR

Life Science

Employees

85

Established

2001

 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
Get Full Access

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Ganymed Pharmaceuticals AG

Life Science Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies
Mergr

Solution for

Product

Company

Legal